Baltruškevičienė E., Mickys U., Žvirblis T., Stulpinas R., Pipirienė Želvienė T. and Aleknavičius E. (2016) “Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience”, Acta medica Lituanica, 23(1), pp. 24-34. doi: 10.6001/actamedica.v23i1.3267.